Doctors and scientists have made significant progress in treating multiple myeloma, a type of blood cancer. While advancements have helped people live longer and healthier lives, there are disparities in care among different racial and ethnic groups. Multiple myeloma is more common in Hispanic and Black populations, who also tend to have a less serious form of the disease but a shorter lifespan. Access to equal healthcare is crucial in improving outcomes for all groups. Stem cell transplants, clinical trials, and genetic research play important roles in treatment, but there is a need for more diversity and inclusivity in these areas to ensure equitable care for all patients.
Source link
Multiple Myeloma in Black and Hispanic Communities
